Who is sponsoring NCT03657433?

NCT03657433 is sponsored by University of Arizona.

What drugs are being tested in NCT03657433?

Interventions in NCT03657433: Ferrous sulfate 325mg, Ferumoxytol.

What condition does NCT03657433 study?

NCT03657433 studies Iron Deficiency Anemia of Pregnancy.

Is NCT03657433 still recruiting?

NCT03657433 is currently completed. Last updated 7 September 2022.

Last reviewed 2022-09-07 · How we verify

NCT03657433

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

Completed Phase 3 Last updated 7 September 2022

What this trial tests

Phase 3 trial testing Ferrous sulfate 325mg in Iron Deficiency Anemia of Pregnancy in 124 participants. Completed in 1 April 2022.

Timeline

17 December 2018

Primary endpoint
27 August 2021

1 April 2022

Quick facts

Lead sponsor	University of Arizona
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	124
Start date	17 December 2018
Primary completion	27 August 2021
Estimated completion	1 April 2022
Sites	1 location across United States

Drugs / interventions tested

Ferrous sulfate 325mg — full drug profile →
Ferumoxytol (FERUMOXYTOL) — full drug profile →

Conditions studied

Iron Deficiency Anemia of Pregnancy — all drugs for Iron Deficiency Anemia of Pregnancy →

Sponsor

University of Arizona

Who can join

Adults 18 to 50, female only, with Iron Deficiency Anemia of Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial includes pregnant women with anemia. They are randomized to IV iron infusions or to oral iron supplementation. Pregnancy outcomes are assessed.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical Trials of Thermosensitive Nanomaterials: An Overview.
Nardecchia S, Sánchez-Moreno P, Sánchez-Moreno P, Vicente J, et al · · 2019 · cited 60× · PMID 30717386 · DOI 10.3390/nano9020191
Effect and safety of intravenous iron compared to oral iron for treatment of iron deficiency anaemia in pregnancy.
Nicholson L, Axon E, Daru J, Rogozińska E. · · 2024 · cited 5× · PMID 39651609 · DOI 10.1002/14651858.cd016136

Verify or expand the search:

Other trials of Ferrous sulfate 325mg

Trials testing the same drug.

NCT03438227 — Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial · Phase 4 · completed

Other recruiting trials for Iron Deficiency Anemia of Pregnancy

Currently open trials in the same condition.

NCT06875947 — EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA · NA · active not recruiting
NCT06366698 — Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia · Phase 3 · recruiting
NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
NCT04008147 — Hepcidin and Glucose Metabolism · NA · recruiting

Other University of Arizona trials

Trials by the same sponsor.

NCT04062890 — Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance · Phase 2 · withdrawn
NCT05569486 — Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain · NA · not yet recruiting
NCT05064111 — Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy · suspended
NCT06567899 — Mechanistic Underpinnings of Preeclampsia · not yet recruiting
NCT07254793 — Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03657433 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arizona
Last refreshed: 7 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03657433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing